BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19459846)

  • 1. Ubiquitin-mediated control of oncogene and tumor suppressor gene products.
    Kitagawa K; Kotake Y; Kitagawa M
    Cancer Sci; 2009 Aug; 100(8):1374-81. PubMed ID: 19459846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis.
    Lau AW; Fukushima H; Wei W
    Front Biosci (Landmark Ed); 2012 Jun; 17(6):2197-212. PubMed ID: 22652772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2).
    Mamillapalli R; Gavrilova N; Mihaylova VT; Tsvetkov LM; Wu H; Zhang H; Sun H
    Curr Biol; 2001 Feb; 11(4):263-7. PubMed ID: 11250155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
    Masumoto K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2).
    Tedesco D; Lukas J; Reed SI
    Genes Dev; 2002 Nov; 16(22):2946-57. PubMed ID: 12435635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
    Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
    PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase.
    Isobe T; Hattori T; Kitagawa K; Uchida C; Kotake Y; Kosugi I; Oda T; Kitagawa M
    J Biol Chem; 2009 Oct; 284(41):27766-27779. PubMed ID: 19679664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of tumor suppression by the SCF(Fbw7).
    Minella AC; Clurman BE
    Cell Cycle; 2005 Oct; 4(10):1356-9. PubMed ID: 16131838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of F-BOX proteins in progression and development of human malignancies.
    Uddin S; Bhat AA; Krishnankutty R; Mir F; Kulinski M; Mohammad RM
    Semin Cancer Biol; 2016 Feb; 36():18-32. PubMed ID: 26410033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase.
    Kamura T; Hara T; Matsumoto M; Ishida N; Okumura F; Hatakeyama S; Yoshida M; Nakayama K; Nakayama KI
    Nat Cell Biol; 2004 Dec; 6(12):1229-35. PubMed ID: 15531880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoform-specific SCF(Fbw7) ubiquitination mediates differential regulation of PGC-1α.
    Trausch-Azar JS; Abed M; Orian A; Schwartz AL
    J Cell Physiol; 2015 Apr; 230(4):842-52. PubMed ID: 25204433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kip1 degradation via the ubiquitin-proteasome pathway.
    Tam SW; Theodoras AM; Pagano M
    Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.
    Welcker M; Orian A; Jin J; Grim JE; Harper JW; Eisenman RN; Clurman BE
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9085-90. PubMed ID: 15150404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor activities of the Fbw7 E3 ubiquitin ligase receptor.
    Fuchs SY
    Cancer Biol Ther; 2005 May; 4(5):506-8. PubMed ID: 15908780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
    Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system.
    Chen G; Wang Y; Garate M; Zhou J; Li G
    Oncogene; 2010 Mar; 29(10):1498-508. PubMed ID: 19935701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.
    Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1).
    Morimoto M; Nishida T; Honda R; Yasuda H
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1093-6. PubMed ID: 10772955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression.
    O'Hagan RC; Ohh M; David G; de Alboran IM; Alt FW; Kaelin WG; DePinho RA
    Genes Dev; 2000 Sep; 14(17):2185-91. PubMed ID: 10970882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination.
    Hiramatsu Y; Kitagawa K; Suzuki T; Uchida C; Hattori T; Kikuchi H; Oda T; Hatakeyama S; Nakayama KI; Yamamoto T; Konno H; Kitagawa M
    Cancer Res; 2006 Sep; 66(17):8477-83. PubMed ID: 16951159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.